This CMTA-funded study is testing a gene therapy approach for CMT4B1, a rare form of CMT that affects the myelin around nerves. Early results are encouraging, showing potential to restore nerve health by delivering a working copy of the affected gene.
Simply CMT
More From Simply CMT
-
CMTA Camp Footprint Launches Fellowship with ACA Grant
A new year-long program helps campers bring the confidence of camp home
-
Walking With CMT: How Strength, Movement, and Sensation Work Together to Improve Stability
For people living with CMT, changes in muscle strength, joint motion, and sensory feedback can make walking feel less stable over time.